Survodutide 10mg - Hubio Pharm: Advanced Metabolic Research Solution
Enhance your metabolic research with Survodutide, a high-purity investigational peptide. Designed for precision-focused studies, this formulation is ideal for researchers investigating the impacts of metabolic regulators on liver health and weight management.
Specifications
| Active Substance | Survodutide |
| Form | 1 vial x 10 mg + 1 vial x 2 ml bac.water |
| Manufacturer | Hubio Pharm |
Description/How it works
Survodutide (BI-456906) is a specialized peptide currently under clinical investigation for its efficacy in treating a range of metabolic conditions, including renal failure, non-alcoholic steatohepatitis (NASH), and liver fibrosis. It is also being studied for its potential applications in managing type 2 diabetes and obesity.
The mechanism of action involves the activation of the glucagon-like peptide 1 receptor (GLP-1R). By targeting this receptor-mediated pathway, Survodutide represents a significant advancement in metabolic research, offering a potential therapeutic avenue for liver and metabolic diseases. This kit is provided with 2 ml of bacteriostatic water to facilitate ease of use and maintaining stability for your research requirements.